Literature DB >> 6710254

Juvenile chronic arthritis in black and Indian South African children.

I E Haffejee, J Raga, H M Coovadia.   

Abstract

Although juvenile chronic arthritis (JCA) has been studied extensively in Whites in Western countries, very few data exist on JCA in children in developing countries and particularly in Africa. Accordingly, a retrospective study of 60 Black and Indian children with JCA was undertaken. The main findings were predominance of JCA of polyarticular onset with a relatively low occurrence of JCA of pauci-articular onset, a high prevalence of positive rheumatoid factor tests and a very low number of patients positive for antinuclear factor, and an equal overall sex ratio (however, there was a preponderance of males in the subgroup with JCA involving only 2 - 4 joints). Moreover, the vast majority of patients initially had a low haemoglobin concentration, a normal white cell count, an elevated erythrocyte sedimentation rate and a positive antistreptolysin O titre. The main differences between Black and Indian South African children with JCA and White children with the disease in Europe and North American appear to be the high prevalences of polyarticular onset and seropositivity, the equal sex ratio and the absence of a specific subgroup with pauci-articular onset and a positive antinuclear factor test.

Entities:  

Mesh:

Year:  1984        PMID: 6710254

Source DB:  PubMed          Journal:  S Afr Med J


  14 in total

1.  Clinico-immunological profile in juvenile rheumatoid arthritis--an Indian experience.

Authors:  V Seth; S K Kabra; O P Semwal; Y Jain
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

Review 2.  Uveitis in children.

Authors:  Sheila T Angeles-Han; Consuelo Egla Rabinovich
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

3.  The Association of Race With Childhood Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Kirsten Jenkins; Daneka Stryker; Curtis Travers; Kelly Rouster-Stevens; Larry B Vogler; Scott R Lambert; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  Am J Ophthalmol       Date:  2015-08-06       Impact factor: 5.258

Review 4.  Spondyloarthritis in sub-Saharan Africa.

Authors:  Mohammed Tikly; Panganani Njobvu; Paul McGill
Journal:  Curr Rheumatol Rep       Date:  2014-06       Impact factor: 4.592

Review 5.  Oligoarticular and polyarticular JIA: epidemiology and pathogenesis.

Authors:  Claudia Macaubas; Khoa Nguyen; Diana Milojevic; Jane L Park; Elizabeth D Mellins
Journal:  Nat Rev Rheumatol       Date:  2009-10-06       Impact factor: 20.543

6.  Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.

Authors:  Sheila T Angeles-Han; Christina F Pelajo; Larry B Vogler; Kelly Rouster-Stevens; Christine Kennedy; Lori Ponder; Courtney McCracken; Jorge Lopez-Benitez; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  J Rheumatol       Date:  2013-11-01       Impact factor: 4.666

7.  Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.

Authors:  Sheila T Angeles-Han; Steven Yeh; Larry B Vogler
Journal:  Int J Clin Rheumtol       Date:  2013-02-01

8.  Juvenile idiopathic arthritis in two tertiary centres in the Western Cape, South Africa.

Authors:  Kate Weakley; Monika Esser; Christiaan Scott
Journal:  Pediatr Rheumatol Online J       Date:  2012-10-10       Impact factor: 3.054

9.  Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Kirsten Jenkins; Daneka Stryker; Kelly Rouster-Stevens; Larry B Vogler; Scott R Lambert; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-02       Impact factor: 3.054

10.  Chronic arthritis in children and adolescents in two Indian health service user populations.

Authors:  Joyce Mauldin; H Dan Cameron; Diane Jeanotte; Glenn Solomon; James N Jarvis
Journal:  BMC Musculoskelet Disord       Date:  2004-08-27       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.